Effect of toll-like receptor 4 inhibitor on LPS-induced lung injury

Inflammation Research

Volumn 59, Issue 10, 2010, Pages 837-845

  Seki, Hiroyuki ^a   Tasaka, Sadatomo ^a   Fukunaga, Koichi ^a   Shiraishi, Yoshiki ^a   Moriyama, Kiyoshi ^a   Miyamoto, Keisuke ^a   Nakano, Yasushi ^a   Matsunaga, Naoko ^b   Takashima, Katsunori ^b   Matsumoto, Tatsumi ^b   Ii, Masayuki ^b   Ishizaka, Akitoshi ^a   Takeda, Junzo ^a  

^a KEIO UNIVERSITY   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Acute lung injury; Endotoxin; NF B; Rodent; Toll like receptor 4

Indexed keywords

6 [N (2 CHLORO 4 FLUOROPHENYL)SULFAMOYL] 1 CYCLOHEXENE 1 CARBOXYLIC ACID ETHYL ESTER; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 4;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; LEUKOCYTE ACTIVATION; LUNG INFILTRATE; LUNG LAVAGE; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN DNA BINDING; RECEPTOR BLOCKING;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; SIGNAL TRANSDUCTION; SULFONAMIDES; TOLL-LIKE RECEPTOR 4;

EID: 77956917528     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0195-3     Document Type: Article

References (36)

1. RC McIntyre Jr EJ Pulido DD Bensard BD Shames E Abraham 2000 Thirty years of clinical trials in acute respiratory distress syndrome Crit Care Med 28 3314 3331 1:CAS:528:DC%2BD3MXjslyhu70%3D 10.1097/00003246-200009000-00034 11008997
2. AD Bersten C Edibam T Hunt J Moran 2002 Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states Am J Respir Crit Care Med 165 443 448 11850334
3. KL Brigham B Meyrick 1986 Endotoxin and lung injury Am Rev Respir Dis 133 913 927 1:CAS:528:DyaL28XktVWksLg%3D 3085564
4. K Takeda S Akira 2004 TLR signaling pathways Semin Immunol 16 3 9 1:CAS:528:DC%2BD2cXntVOnsA%3D%3D 10.1016/j.smim.2003.10.003 14751757 (Pubitemid 38147427)
5. DC Morrison JL Ryan 1979 Bacterial endotoxins and host immune responses Adv Immunol 28 293 450 1:CAS:528:DyaL3cXksVentLw%3D 10.1016/S0065-2776(08)60802- 0 396770
6. S Jeyaseelan HW Chu SK Young MW Freeman GS Worthen 2005 Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury Infect Immun 73 1754 1763 1:CAS:528:DC%2BD2MXit12msbo%3D 10.1128/IAI.73.3.1754-1763.2005 15731076 (Pubitemid 40470764)
7. D Togbe S Schnyder-Candrian B Schnyder I Couillin I Maillet F Bihl D Malo B Ryffel VF Quesniaux 2006 TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation J Leukoc Biol 80 451 457 1:CAS:528: DC%2BD28XpsVOnu7k%3D 10.1189/jlb.0206099 16809643 (Pubitemid 44835777)
8. E Abraham PF Laterre J Garbino S Pingleton T Butler T Dugernier B Margolis K Kudsk W Zimmerli P Anderson M Reynaert D Lew W Lesslauer S Passe P Cooper A Burdeska M Modi A Leighton M Salgo P Van der Auwera Lenercept Study Group 2001 Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase iii trial with 1,342 patients Crit Care Med 29 503 510 1:CAS:528:DC%2BD3MXntFKhtLo%3D 10.1097/00003246-200103000-00006 11373411
9. SM Opal CJ Fisher Jr JF Dhainaut JL Vincent R Brase SF Lowry JC Sadoff GJ Slotman H Levy RA Balk MP Shelly JP Pribble JF LaBrecque J Lookabaugh H Donovan H Dubin R Baughman J Norman E DeMaria K Matzel E Abraham M Seneff 1997 Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group Crit Care Med 25 1115 1124 1:STN:280:DyaK2szns12ltg%3D%3D 10.1097/00003246-199707000-00010 9233735 (Pubitemid 27310249)
10. M Shiozaki H Doi D Tanaka T Shimozato S Kurakata 2006 Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate Bioorg Med Chem 14 3011 3016 1:CAS:528:DC%2BD28Xis1eiu7c%3D 10.1016/j.bmc.2005.12.018 16403638
11. M Ii N Matsunaga K Hazeki K Nakamura K Takashima T Seya O Hazeki T Kitazaki Y Iizawa 2006 A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling Mol Pharmacol 69 1288 1295 1:CAS:528:DC%2BD28XjtlKntLs%3D 10.1124/mol.105.019695 16373689
12. T Sha M Sunamoto T Kitazaki J Sato M Ii Y Iizawa 2007 Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model Eur J Pharmacol 571 231 239 1:CAS:528:DC%2BD2sXhtVCitrrL 10.1016/j.ejphar.2007.06.027 17632100 (Pubitemid 47379694)
13. E Shirley 1977 A non-parametric equivalent of Williams' test for contrasting increasing dose levels of a treatment Biometrics 33 386 389 1:STN:280:DyaE2s3it1ansQ%3D%3D 10.2307/2529789 884197
14. DA Williams 1986 A note on Shirley's nonparametric test for comparing several dose levels with a zero-dose control Biometrics 42 183 186 1:STN:280:DyaL283ktlGltg%3D%3D 10.2307/2531254 3719054
15. TS Olson K Ley 2002 Chemokines and chemokine receptors in leukocyte trafficking Am J Physiol Regul Integr Comp Physiol 283 R7 R28 1:CAS:528:DC%2BD38XlsVCksb0%3D 12069927
16. MS Hayden AP West S Ghosh 2006 NF-κB and the immune response Oncogene 25 6758 6780 1:CAS:528:DC%2BD28XhtFektL7P 10.1038/sj.onc.1209943 17072327 (Pubitemid 44657851)
17. JC Chow DW Young DT Golenbock WJ Christ F Gusovsky 1999 Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J Biol Chem 274 10689 10692 1:CAS:528:DyaK1MXis1Gntbw%3D 10.1074/jbc.274.16.10689 10196138 (Pubitemid 29191043)
18. RJ Ulevitch PS Tobias 1995 Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin Annu Rev Immunol 13 437 457 1:CAS:528:DyaK2MXltFamur0%3D 10.1146/annurev.iy.13.040195.002253 7542010
19. R Shimazu S Akashi H Ogata Y Nagai K Fukudome K Miyake M Kimoto 1999 MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J Exp Med 189 1777 1782 1:CAS:528:DyaK1MXjvVSnu78%3D 10.1084/jem.189.11.1777 10359581 (Pubitemid 29272694)
20. SD Wright RA Ramos PS Tobias RJ Ulevitch JC Mathison 1990 CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 1431 1433 1:CAS:528:DyaK3MXksV2q 10.1126/science.1698311 1698311
21. JW Christman LH Lancaster TS Blackwell 1998 Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy Intensive Care Med 24 1131 1138 1:STN:280:DyaK1M%2Fpt1yjsw%3D%3D 10.1007/s001340050735 9876974 (Pubitemid 28542926)
22. WY Xu L Wang HM Wang YQ Wang YF Liang TT Zhao YZ Wu 2007 TLR2 and TLR4 agonists synergistically up-regulate SR-A in RAW264.7 through p38 Mol Immunol 44 2315 2323 1:CAS:528:DC%2BD2sXntVKhuw%3D%3D 10.1016/j.molimm.2006.11.013 17173973 (Pubitemid 46097120)
23. M Hirschfeld Y Ma JH Weis SN Vogel JJ Weis 2000 Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2 J Immunol 165 618 622 1:CAS:528: DC%2BD3cXkvFWisro%3D 10878331
24. Y Xue D Yun A Esmon P Zou S Zuo Y Yu F He P Yang X Chen 2008 Proteomic dissection of agonist-specific TLR-mediated inflammatory responses on macrophages at subcellular resolution J Proteome Res 7 3180 3193 1:CAS:528:DC%2BD1cXns1Wjsr4%3D 10.1021/pr800021a 18572962
25. T Kawamoto M Ii T Kitazaki Y Iizawa H Kimura 2008 Tak-242 selectively suppresses toll-like receptor 4-signaling mediated by the intracellular domain Eur J Pharmacol 584 40 48 1:CAS:528:DC%2BD1cXktVKrtro%3D 10.1016/j.ejphar.2008. 01.026 18299127
26. K Takashima N Matsunaga M Yoshimatsu K Hazeki T Kaisho M Uekata O Hazeki S Akira Y Iizawa M Ii 2009 Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model Br J Pharmacol 157 7 1250 1262 1:CAS:528:DC%2BD1MXhtVelt7bL 10.1111/j.1476-5381.2009.00297.x 19563534
27. M Bhatia S Moochhala 2004 Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome J Pathol 202 145 156 1:CAS:528:DC%2BD2cXhvVKjtr4%3D 10.1002/path.1491 14743496 (Pubitemid 38208651)
28. CF Nathan 1987 Secretory products of macrophages J Clin Invest 79 319 326 1:CAS:528:DyaL2sXhtFOlt7w%3D 10.1172/JCI112815 3543052
29. KP Steinberg JA Milberg TR Martin RJ Maunder BA Cockrill LD Hudson 1994 Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome Am J Respir Crit Care Med 150 113 122 1:STN:280:DyaK2c3pslyhtA%3D%3D 8025736
30. PE Parsons AA Fowler TM Hyers PM Henson 1985 Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome Am Rev Respir Dis 132 490 493 1:STN:280:DyaL2MzgsFWgsQ%3D%3D 4037522
31. MA Matthay 1999 Conference summary: acute lung injury Chest 116 119S 126S 1:STN:280:DyaK1MzltF2itQ%3D%3D 10.1378/chest.116.suppl-1.119S 10424631 (Pubitemid 29340249)
32. J Reutershan K Ley 2004 Bench-to-bedside review: acute respiratory distress syndrome-how neutrophils migrate into the lung Crit Care 8 453 461 10.1186/cc2881 15566616 (Pubitemid 40073680)
33. JR Schurr E Young P Byrne C Steele JE Shellito JK Kolls 2005 Central role of Toll-like receptor 4 signaling and host defense in experimental pneumonia caused by gram-negative bacteria Infect Immun 73 532 545 1:CAS:528: DC%2BD2MXisFyktQ%3D%3D 10.1128/IAI.73.1.532-545.2005 15618193 (Pubitemid 40041148)
34. PB Mann MJ Kennett ET Harvill 2004 Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis J Infect Dis 189 833 836 1:CAS:528:DC%2BD2cXivFant7Y%3D 10.1086/381898 14976600 (Pubitemid 38328184)
35. KD Lettinga S Florquin P Speelman R van Ketel T van der Poll A Verbon 2002 Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model J Infect Dis 186 570 573 1:CAS:528:DC%2BD38XntVyjtbs%3D 10.1086/341780 12195388 (Pubitemid 34876270)
36. JS Lee CW Frevert G Matute-Bello MM Wurfel VA Wong SM Lin J Ruzinski S Mongovin RB Goodman TR Martin 2005 TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia Am J Physiol Lung Cell Mol Physiol 289 L731 L738 1:CAS:528:DC%2BD2MXht1Cnt73F 10.1152/ajplung. 00196.2005 16024722 (Pubitemid 41504404)